News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
TradingView Earnings
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
This document is a Statement of Changes in Beneficial Ownership of Securities, specifically Form 4, filed by Joseph Ronald Catapano, an officer at Teladoc Health. This filing indicates a change in his beneficial ownership of securities in the company.
Bronstein, Gewirtz & Grossman, LLC has launched an investigation into Teladoc Health, Inc. (TDOC) following the company's Q2 2026 financial results, which reported lower-than-expected revenue and a reduced full-year guidance. The investigation focuses on potential claims for purchasers of Teladoc Health securities, especially after …
Teladoc Health's stock rose 6.7% following the acceleration of BetterHelp's nationwide insurance rollout, prompted by higher-than-expected insured demand. This shift, however, reduced the overall BetterHelp revenue outlook due to provider capacity constraints and a quicker move away from cash-pay users. The company's updated guidance …
Teladoc Health (TDOC) is a leading virtual healthcare provider facing financial challenges despite its innovative role in the sector. The company has a market capitalization of $1.21 billion, with recent revenue decline and negative EPS, yet it maintains a healthy free cash flow. Analysts …
This article provides the current stock information for Teladoc Health Inc (TDOC), including its trading price, daily change, market capitalization, and a note that more news will be available soon. It highlights that the stock closed at 7.130 USD, up 6.74%, with a market …
Levi & Korsinsky has announced a securities investigation into Teladoc Health (TDOC) after its shares dropped over 28%. This plunge followed Teladoc's report of Q2 2026 revenue below consensus and a cut in its full-year 2026 revenue guidance. The investigation focuses on potential materially …
Pomerantz LLP is investigating potential claims on behalf of investors of Teladoc Health, Inc. (NYSE: TDOC) concerning alleged securities fraud or unlawful business practices. This investigation follows Teladoc's updated 2026 revenue guidance, which was significantly lowered due to "uncertainties inherent in cash pay and …
Bronstein, Gewirtz & Grossman, LLC is investigating Teladoc Health, Inc. (TDOC) on behalf of investors following a significant drop in its stock price. This drop occurred after Teladoc reported lower-than-expected Q2 2026 revenue and subsequently reduced its full-year 2026 revenue guidance. The firm cites …
The Law Offices of Frank R. Cruz has initiated a securities fraud investigation into Teladoc Health Inc. (TDOC) following a significant drop in its stock price. This investigation comes after Teladoc reduced its full-year revenue guidance and reported a more drastic reduction in BetterHelp's …
Dimensional Fund Advisors LP significantly reduced its stake in Teladoc Health, Inc. by 16% in the first quarter, selling 1.2 million shares but still retaining over 6.3 million shares valued at approximately $34.3 million. Despite beating EPS estimates, Teladoc's revenue declined year-over-year and missed …
Bronstein, Gewirtz & Grossman, LLC has launched an investigation into Teladoc Health, Inc. (TDOC) following the company's Q2 2026 financial results, which reported lower-than-expected revenue and a reduced full-year guidance. The investigation focuses on potential claims for investors who purchased Teladoc Health securities, especially …
Teladoc Health Inc. (NYSE: TDOC) director Mark V. Anquillare has filed an initial Form 3, indicating his beneficial ownership of securities as a director. The filing reports no equity transactions and includes a reference to a Power of Attorney. This Form 3 establishes Anquillare's …
This article reports a change in the beneficial ownership of securities for Mark V. Anquillare, a Director at Teladoc Health. The filing is a Statement of Changes in Beneficial Ownership, also known as a Form 4. This indicates that there has been a transaction …
This article provides an overview of Teladoc Health (TDOC), a company specializing in telehealthcare services. It details the company's profile, including its founding, headquarters, CEO, and employee count, alongside key financial statistics, stock price performance, and analyst consensus recommendations.
Teladoc Health director Mark V. Anquillare was granted 37,425 Restricted Stock Units (RSUs) on August 3, 2026. These RSUs, which represent a contingent right to one share of common stock each, will vest in a staggered manner: one-third on the first anniversary of the …
Teladoc Health (TDOC) is facing renewed scrutiny after reporting weaker Q2 revenue, a wider net loss, and reduced full-year guidance, leading to a significant stock pullback. Despite a narrative suggesting the stock is 55.5% undervalued with a fair value of $15.00 due to its …
Teladoc Health, Inc. has announced the appointment of Mark V. Anquillare to its board of directors, effective August 3, 2026. Mr. Anquillare, former president and COO of Verisk Analytics, brings over 30 years of financial and executive leadership experience. He will serve on the …
Teladoc Health (NYSE: TDOC) has announced the appointment of financial executive Mark V. Anquillare to its board of directors. Mr. Anquillare, former president and chief operating officer of Verisk Analytics, will serve on the board’s Audit & Compensation committees, bringing over 30 years of …
This document is an 8-K current report filed by Teladoc Health. The content of the report itself is not provided in the input, only the document type.
SueWallSt is investigating potential securities law violations by Teladoc Health (TDOC) after the company cut its full-year 2026 revenue guidance, leading to a nearly 30% drop in stock value. The investigation focuses on whether Teladoc made false or misleading statements about its revenue outlook. …
The article analyzes why Teladoc Health (TDOC) might be undervalued, highlighting its Zacks Rank #2 (Buy) and an "A" grade for Value. It uses metrics like P/B, P/S, and P/CF ratios to demonstrate that TDOC's valuation is attractive compared to its industry averages. The …
Teladoc Health's BetterHelp division experienced a significant shift towards insurance-covered therapy, leading to a 12% revenue decline as increased demand outpaced provider capacity and could not offset a sharp drop in cash-pay customers. While insurance-covered services saw over a tenfold revenue increase, the transition …
Teladoc Health (TDOC) reported a challenging Q2 2026 with declining sales, a wider net loss, and lowered full-year 2026 guidance, primarily due to struggles in its BetterHelp mental health unit as users shift to insurance-covered care. This performance pressures the company's investment narrative, which …
Teladoc Health (TDOC) had 5,704 employees worldwide as of March 2026, marking a 1.7% decline from 2023 but a recovery from a low in 2025. The company is actively hiring with 611 job postings in 2026, and its workforce is primarily concentrated in the …
Levi & Korsinsky, LLP has announced an investigation into Teladoc Health (TDOC) after the company's stock dropped over 28% following a disappointing Q2 2026 earnings report and reduced full-year revenue guidance. The investigation focuses on whether Teladoc made false or misleading statements regarding its …
Teladoc Health (TDOC) shares have seen a significant drop after reporting weaker-than-expected Q2 2026 results and revised guidance. Despite recent poor performance, one valuation narrative suggests TDOC could be 56% undervalued with a fair value of $15.00, driven by potential success in its BetterHelp …
Teladoc Health's stock price dropped over 28% after its Q2 2026 earnings report, largely due to a "reset" in its BetterHelp segment. While Integrated Care showed some positive signs, BetterHelp experienced an 11.6% revenue decline and near break-even EBITDA as it transitions from cash …
Teladoc Health has lowered its full-year revenue outlook by 5% due to significant challenges at its mental health unit, BetterHelp. The segment experienced unexpectedly high consumer demand for its insurance offering, which it struggled to meet, causing a faster-than-anticipated decline in its cash-pay business. …
Search by ticker symbol or company name and select a result to open its chart.